EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Structural insights reveal interplay between LAG-3 homodimerization, ligand binding, and function

John L Silberstein iD, Jasper Du iD, Kun-Wei Chan, Jessica A Frank iD, Irimpan I Mathews, Yong Bin Kim iD, Jia You, Qiao Lu iD, Jia Liu iD, Elliot A Philips iD, Phillip Liu iD, Eric Rao und 5 weitere

Proceedings of the National Academy of Sciences · 2024

DOI: 10.1073/pnas.2310866121 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, 2024. Verfasst von John L Silberstein und 16 weiteren Autor:innen. Beteiligte Einrichtung: Program in Immunology, Stanford University School of Medicine, Stanford, CA 94305. Hauptthemen laut MEDLINE: Histocompatibility Antigens Class II, T-Lymphocytes. Die Arbeit wurde bisher 46-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIH HHS, NCI NIH HHS, NIAID NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Lymphocyte activation gene-3 (LAG-3) is an inhibitory receptor expressed on activated T cells and an emerging immunotherapy target. Domain 1 (D1) of LAG-3, which has been purported to directly interact with major histocompatibility complex class II (MHCII) and fibrinogen-like protein 1 (FGL1), has been the major focus for the development of therapeutic antibodies that inhibit LAG-3 receptor-ligand interactions and restore T cell function. Here, we present a high-resolution structure of glycosylated mouse LAG-3 ectodomain, identifying that cis-homodimerization, mediated through a network of hydrophobic residues within domain 2 (D2), is critically required for LAG-3 function. Additionally, we found a previously unidentified key protein-glycan interaction in the dimer interface that affects the spatial orientation of the neighboring D1 domain. Mutation of LAG-3 D2 residues reduced dimer formation, dramatically abolished LAG-3 binding to both MHCII and FGL1 ligands, and consequentially inhibited the role of LAG-3 in suppressing T cell responses. Intriguingly, we showed that antibodies directed against D1, D2, and D3 domains are all capable of blocking LAG-3 dimer formation and MHCII and FGL-1 ligand binding, suggesting a potential allosteric model of LAG-3 function tightly regulated by dimerization. Furthermore, our work reveals unique epitopes, in addition to D1, that can be targeted for immunotherapy of cancer and other human diseases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Histocompatibility Antigens Class IIT-LymphocytesAnimalsHumansMiceDimerizationFibrinogenLigandsMutationLymphocyte Activation Gene 3 Protein

Stichwörter der Autor:innen

LAG-3cancer immunotherapydimerizationimmune checkpointstructural biology

Substanzen

FibrinogenHistocompatibility Antigens Class IILigandsFGL1 protein, humanLag3 protein, mouseLymphocyte Activation Gene 3 Protein

Autor:innen und Institutionen

  • Program in Immunology, Stanford University School of Medicine, Stanford, CA 94305.
  • Department of Bioengineering, Stanford University, Stanford, CA 94305.
  • Department of Pathology, New York University Grossman School of Medicine, New York, NY 10016.
  • Department of Biochemistry and Molecular Pharmacology, New York University Grossman School of Medicine, New York, NY 10016.
  • SLAC National Accelerator Laboratory, Stanford Synchrotron Radiation Lightsource, Menlo Park, CA 94025.
  • Department of Chemical Engineering, Stanford University, Stanford, CA 94305.

ORCID-Profile: John L Silberstein, Jasper Du, Jessica A Frank, Yong Bin Kim, Qiao Lu, Jia Liu, Elliot A Philips, Phillip Liu, Daniel Fernandez, Grayson E Rodriguez, Jun Wang

Förderung

  • NIH HHS
  • NCI NIH HHS
  • NIAID NIH HHS
  • NIGMS NIH HHS
  • NIAMS NIH HHS
  • Emerson Collective
  • HHS | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases
  • NIH

Zitieren

APA

Silberstein, J. L., Du, J., Chan, K. W., Frank, J. A., Mathews, I. I., Kim, Y. B., You, J., Lu, Q., Liu, J., Philips, E. A., Liu, P., Rao, E., Fernandez, D., Rodriguez, G. E., Kong, X. P., Wang, J., & Cochran, J. R. (2024). Structural insights reveal interplay between LAG-3 homodimerization, ligand binding, and function. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.2310866121

Vancouver

Silberstein JL, Du J, Chan KW, Frank JA, Mathews II, Kim YB, et al. Structural insights reveal interplay between LAG-3 homodimerization, ligand binding, and function. Proceedings of the National Academy of Sciences. 2024. doi:10.1073/pnas.2310866121

BibTeX
@article{Silberstein2024,
  author = {Silberstein, John L and Du, Jasper and Chan, Kun-Wei and Frank, Jessica A and Mathews, Irimpan I and Kim, Yong Bin and You, Jia and Lu, Qiao and Liu, Jia and Philips, Elliot A and Liu, Phillip and Rao, Eric and Fernandez, Daniel and Rodriguez, Grayson E and Kong, Xiang-Peng and Wang, Jun and Cochran, Jennifer R},
  title = {Structural insights reveal interplay between LAG-3 homodimerization, ligand binding, and function},
  journal = {Proceedings of the National Academy of Sciences},
  year = {2024},
  doi = {10.1073/pnas.2310866121}
}
Kostenlos starten →